Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia

NCT01254422 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Dengue Fever
Dengue Hemorrhagic Fever

Interventions

BIOLOGICAL: Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
BIOLOGICAL: Placebo: NaCl 0.9%

Sponsor

Sanofi